Dolly A. Vance
2020
In 2020, Dolly A. Vance earned a total compensation of $1.2M as Executive Vice President, Corporate Affairs, General at Rigel Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $200,770 |
---|---|
Option Awards | $459,869 |
Salary | $524,890 |
Other | $9,054 |
Total | $1,194,583 |
Vance received $524.9K in salary, accounting for 44% of the total pay in 2020.
Vance also received $200.8K in non-equity incentive plan, $459.9K in option awards and $9.1K in other compensation.
Rankings
In 2020, Dolly A. Vance's compensation ranked 7,856th out of 13,090 executives tracked by ExecPay. In other words, Vance earned more than 40.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,856 | 40th |
Manufacturing | 3,323 | 41st |
Chemicals And Allied Products | 1,347 | 40th |
Drugs | 1,169 | 40th |
Pharmaceutical Preparations | 871 | 40th |
Vance's colleagues
We found four more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2020.